CINECA IRIS Institutional Research Information System

CERAVOLO, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.248
AS - Asia 10.845
EU - Europa 8.888
SA - Sud America 1.718
AF - Africa 497
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 14
Totale 44.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.625
SG - Singapore 3.467
CN - Cina 3.363
IT - Italia 3.132
HK - Hong Kong 2.052
BR - Brasile 1.449
SE - Svezia 1.388
DE - Germania 953
BG - Bulgaria 774
VN - Vietnam 574
GB - Regno Unito 510
CA - Canada 470
RU - Federazione Russa 398
FI - Finlandia 386
TR - Turchia 358
AT - Austria 353
KR - Corea 291
UA - Ucraina 287
IN - India 215
FR - Francia 187
CI - Costa d'Avorio 185
CH - Svizzera 120
AR - Argentina 105
PL - Polonia 90
JP - Giappone 89
NL - Olanda 85
MX - Messico 83
BD - Bangladesh 70
SN - Senegal 69
ZA - Sudafrica 67
ES - Italia 59
IQ - Iraq 56
NG - Nigeria 50
MA - Marocco 47
EC - Ecuador 38
ID - Indonesia 37
AU - Australia 35
SA - Arabia Saudita 34
BE - Belgio 33
PK - Pakistan 31
UZ - Uzbekistan 31
LT - Lituania 29
CO - Colombia 26
KE - Kenya 25
VE - Venezuela 24
IE - Irlanda 23
PY - Paraguay 23
CZ - Repubblica Ceca 21
JO - Giordania 18
EG - Egitto 17
PE - Perù 17
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 14
CL - Cile 14
IL - Israele 13
MY - Malesia 13
UY - Uruguay 13
BJ - Benin 11
EU - Europa 11
PH - Filippine 11
NP - Nepal 10
PA - Panama 10
KG - Kirghizistan 9
DO - Repubblica Dominicana 8
IR - Iran 8
JM - Giamaica 8
OM - Oman 8
PT - Portogallo 8
DZ - Algeria 7
GT - Guatemala 7
LB - Libano 7
TW - Taiwan 7
AM - Armenia 6
BO - Bolivia 6
CR - Costa Rica 6
GR - Grecia 6
KZ - Kazakistan 6
RS - Serbia 6
TN - Tunisia 6
AL - Albania 5
EE - Estonia 5
HN - Honduras 5
LV - Lettonia 5
NI - Nicaragua 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CY - Cipro 4
GA - Gabon 4
GE - Georgia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AO - Angola 3
BN - Brunei Darussalam 3
HU - Ungheria 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 44.202
Salva come PNG Salva come JPEG
Città #
Ashburn 2.534
Hong Kong 2.037
Woodbridge 1.951
Fairfield 1.863
Singapore 1.852
Dallas 1.496
Ann Arbor 1.348
Houston 1.338
Chandler 1.263
Santa Clara 1.047
Shanghai 923
Milan 863
Seattle 810
Sofia 771
Wilmington 695
New York 608
Cambridge 584
Beijing 562
Serra 525
Boardman 448
Jacksonville 395
Hefei 392
Princeton 382
Ottawa 366
Los Angeles 358
Vienna 313
Lawrence 301
Seoul 281
Medford 279
Munich 262
Pisa 201
Frankfurt am Main 194
Izmir 192
Nanjing 191
Abidjan 185
Florence 184
Des Moines 179
Dearborn 154
Buffalo 142
Redondo Beach 126
Istanbul 125
London 123
São Paulo 119
Ho Chi Minh City 118
Bern 113
Turku 113
Dong Ket 112
Rome 103
San Diego 102
Chicago 79
Nanchang 79
Bremen 75
Warsaw 71
Tokyo 70
Dakar 69
Jüchen 67
Redwood City 65
San Jose 63
Lancaster 59
Norwalk 59
Guangzhou 57
Ogden 57
Shenyang 56
Hanoi 53
Helsinki 53
Kunming 53
Lagos 49
Lucca 47
Fuzhou 44
Hebei 44
Düsseldorf 40
Changsha 39
Nuremberg 39
Belo Horizonte 38
Columbus 37
Pune 36
The Dalles 36
Brooklyn 35
Council Bluffs 35
Johannesburg 35
San Francisco 35
Baghdad 32
Brussels 32
Phoenix 31
Quanzhou 31
Rio de Janeiro 31
Tianjin 31
Chennai 30
Mexico City 30
Denver 29
Paris 29
Toronto 29
Vicopisano 29
Casablanca 28
Trieste 28
Montreal 27
Orem 27
Tashkent 27
Curitiba 26
Poplar 26
Totale 31.850
Salva come PNG Salva come JPEG
Nome #
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers 371
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 310
Cataract surgery under topical anesthesia in a patient with Parkinson disease and deep brain stimulation: a report of feasibility. 283
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 259
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 249
Serotonin and neurodegeneration: a preliminary study of platelet serotonin transporter (SERT) in patients with Huntington's disease 237
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 218
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 214
Disfunzioni sessuali nel morbo di Parkinson: review 212
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 212
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 209
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 209
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 207
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 203
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 201
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 200
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 200
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 199
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 199
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 196
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 195
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 194
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 194
A case of pelvic floor myoclonic jerk syndrome. 193
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 193
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 192
Leadless cardiac pacemaker implant in a patient with two deep brain stimulators: a peaceful cohabitation beyond prejudices 191
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 188
The hOGG1 Ser326Cys polymorphism and Huntington's disease 187
Mitochondrial DNA single deletion in a patient with postural tremor. 185
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 184
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 184
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 182
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 180
Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy: A possible role in drug resistance 176
Antipsychotic drugs in Huntington's disease 176
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 175
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 174
Acute and chronic effects of clozapine in essential tremor 173
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 171
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 171
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 171
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 170
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result 168
Depressive symptoms in Parkinson's disease 167
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 166
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 166
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals 163
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 163
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 163
Antioxidants in the Diet and Cognitive Function: Which Role for the Mediterranean Life-style? 163
SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study 162
Psychosis associated to Parkinson's disease in the early stages: Relevance of cognitive decline and depression 161
Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study 161
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 160
Morphometric and functional MRI changes in essential tremor with and without resting tremore. 159
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. 159
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 158
Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study 158
Myopathic involvement in two cases of Hallervorden-Spatz disease 157
Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients 157
The Italian Dystonia Registry: rationale, design and preliminary findings 157
Oxidative stress assessment in Alzheimer's disease: a clinic setting study 157
Expanding the clinical phenotype of DYT5 mutations: is multiple system atrophy a possible one? 156
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. 156
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients 155
Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. 155
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 155
Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers 155
Decision making in de novo Parkinson's disease 154
Non-motor symptoms in atypical and secondary parkinsonism: The PRIAMO study 154
Correlation between vestibular abnormalities and MRI findings in cerebellar ataxia 153
The association between motor subtypes and alexithymia in de novo Parkinson's disease. 152
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy 151
Association between amantadine and the onset of dementia in Parkinson's disease 151
Iowa Gambling Task in de novo Parkinson's disease: a comparison between good and poor performers 150
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 150
Apomorphine hydrochloride for the treatment of Parkinson's disease. 149
The mtDNA A8344G "MERRF" mutation is not a common cause of sporadic Parkinson disease in Italian population 148
Sindrome da encefalopatia posteriore reversibile (PRES) in una paziente psoriasica in trattamento con ciclosporina 147
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items". 147
Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study. 147
Quantitative susceptibility mapping in atypical Parkinsonisms 147
Symptomatic orthostatic tremor associated with Graves' disease. 146
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 146
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire 145
Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study 145
Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension 145
Clinical/scientific notes 145
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 144
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 144
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 143
Nonmotor symptoms in Parkinson’s disease: the dark side of the moon 143
Current treatment and future prospects of dopa-induced dyskinesias. 142
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 142
Reliability of administrative data for the identification of Parkinson's disease cohorts. 142
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. 142
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging 141
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 141
Evaluating the SERCA2 and VEGF mRNAs as potential molecular biomarkers of the onset and progression in huntington's disease 141
Totale 17.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.406 0 0 0 0 0 0 287 186 240 174 136 383
2021/20223.333 44 125 71 254 657 440 93 177 199 99 226 948
2022/20234.304 565 538 342 357 464 542 37 311 764 23 281 80
2023/20243.857 454 412 407 318 563 764 140 134 30 69 179 387
2024/202510.955 115 417 178 571 792 955 1.076 513 1.161 1.565 1.373 2.239
2025/20268.137 953 1.625 1.740 1.238 1.409 1.137 35 0 0 0 0 0
Totale 44.895